Mahmood Hussain
Chylos, Inc.
Affiliations
State University of New York
Technologies
Therapeutic
Indication
Cardiovascular Disease
Metabolic Disease
Obesity
Website
www.chylostherapeutics.comWe have discovered a microRNA, miR-30c, which lowers plasma cholesterol and atherosclerosis in mice. We would like to commercialize it as a drug to treat hyperlipidemia and atherosclerosis.
